Predictive Modeling of Proliferative Diabetic Retinopathy and DME Based on Analysis of High-Value Biomarkers

Related

• 

  Expert Panel: Faricimab and Aflibercept 8 mg in Diabetic Retinopathy

  Judy E. Kim, MD, FASRS

  Chirag D. Jhaveri, MD, FASRS

  Michael S. Ip, MD

  Arshad M. Khanani, MD, MA, FASRS

  Jordana G Fein, MD, MS

  Dennis M. Marcus, MD

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2024

• 

  Future DME Therapeutics

  Updates from the Field

  2017

• 

  Impact of Posterior Vitreous Detachment at Baseline on Treatment Outcomes For Diabetic Macular Edema in the VISTA and VIVID Trials

  Ferhina S Ali, MD, MPH

  On Demand Cases, Courses, and Papers

  2017